Publikationen in Zusammenarbeit mit Forschern von Stanford University (3)

2019

  1. Assessment of disease progression in dysferlinopathy: A 1-year cohort study

    Neurology, Vol. 92, Núm. 5, pp. E461-E474

2016

  1. Phosphotyrosine phosphatase inhibitor bisperoxovanadium endows myogenic cells with enhanced muscle stem cell functions via epigenetic modulation of Sca-1 and Pw1 promoters

    FASEB Journal, Vol. 30, Núm. 4, pp. 1404-1415

  2. Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy

    Nature Communications, Vol. 7